AQR CAPITAL MANAGEMENT LLC

Position in AVIR — Atea Pharmaceuticals, Inc.

CIK 1167557 Greenwich, CT

Position in AVIR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,151,848

+$903,784 QoQ

Shares Held

247,710

+437.2% QoQ

Ownership

0.309%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#28

of 124 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,647,082,401 across 216 Biotechnology names. AVIR ranks #147 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,126,080	$702,155,918
2	INCY	Incyte Corp	5,320,901	$603,177,333
3	EXEL	Exelixis, Inc.	11,023,943	$599,812,735
4	JAZZ	Jazz Pharmaceuticals plc	1,522,568	$366,893,205
5	BMRN	Biomarin Pharmaceutical Inc	5,699,541	$326,127,732
6	VRTX	Vertex Pharmaceuticals Inc / Ma	616,170	$306,070,117
7	RVMD	Revolution Medicines, Inc.	1,295,450	$242,611,869
8	RPRX	Royalty Pharma plc	4,305,412	$241,404,446

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,151,848	247,710	+437.2%	Shares	Other	2026-08-14
2026-03-31	$248,064	46,109	+222.5%	Shares	Defined	2026-05-15
2025-12-31	$51,041	14,298	+6.6%	Shares	Other	2026-02-17
2025-09-30	$38,888	13,410	+2.0%	Shares	Other	2025-11-14
2024-09-30	$44,028	13,143	-56.7%	Shares	Other	2024-11-14
2023-09-30	$91,059	30,353	-9.6%	Shares	Defined	2023-11-14
2023-06-30	$125,626	33,590	-75.5%	Shares	Defined	2023-08-14
2023-03-31	$459,221	137,081	-9.2%	Shares	Defined	2023-05-15
2022-12-31	$725,771	150,888	+394.5%	Shares	Defined	2023-02-14
2022-09-30	$173,613	30,512	-71.8%	Shares	Defined	2022-11-14
2022-06-30	$768,908	108,297	-61.5%	Shares	Defined	2022-08-15
2022-03-31	$2,032,249	281,475	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.